Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

Home

/

NBIX

N

Neurocrine Biosciences, Inc. (NBIX)

NMS – Real Time Price. Currency in USD

158.25

-3.69 (-2.28%)

Market open: Aug 12, 2026, 10:47 AM EDT

161.94

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

2.86B

2.36B

1.89B

1.49B

Cost of goods sold

-52M

-58M

-58M

-38M

Gross Profit

2.81B

2.30B

1.83B

1.45B

Operating expenses (excl. COGS)

-2.17B

-1.70B

-1.43B

-1.20B

Operating Income

637M

597M

395M

251M

Non-operating income, total

69M

-111M

-63M

-37M

Pretax income

705M

486M

332M

214M

Equity in earnings

0

0

0

0

Taxes

-227M

-145M

-82M

-59M

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

479M

341M

250M

155M

Discontinued operations

0

0

0

0

Net income

479M

341M

250M

155M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

4.75B+23.6%

3.85B+15.5%

3.33B+38.7%

2.40B

Total current assets

2.52B

1.72B

1.61B

1.45B

Total non-current assets

2.23B

2.12B

1.72B

948M

Total liabilities

1.50B+19.3%

1.26B+14.5%

1.10B+58.3%

694M

Total current liabilities

743M

508M

655M

538M

Total non-current liabilities

757M

750M

443M

156M

Total equity

3.25B

2.59B

2.23B

1.71B

Total liabilities & shareholders' equities

4.75B

3.85B

3.33B

2.40B

Total debt

471M-4.9%

496M+7.7%

460M+64.3%

280M

Name

2025

2024

2023

2022

Cash from operating activities

783M

595M

390M

339M

Cash from investing activities

-264M

-127M

-467M

-177M

Cash from financing activities

-38M

-487M

65M

-234M

Free cash flow

749M+34.4%

557M+54.1%

362M+12.0%

323M